CD81 is required for hepatitis C virus glycoprotein-mediated viral infection - sprookjes - yvandenbroek - TriplyDB

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

http://www.wikidata.org/entity/Q29619745

about

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain Dual function of CD81 in influenza virus uncoating and budding Cellular cofactors affecting hepatitis C virus infection and replication Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81 Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus Potential cellular receptors involved in hepatitis C virus entry into cells Roles of lipoprotein receptors in the entry of hepatitis C virus Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases Recent advances in live cell imaging of hepatoma cells Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells.Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.Robust hepatitis C virus infection in vitro.Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein Tetraspanins in viral infections: a fundamental role in viral biology?Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay.Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host Diverse CD81 Proteins Support Hepatitis C Virus Infection Expression of DC-SIGN and DC-SIGNR on Human Sinusoidal Endothelium The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells Superinfection Exclusion in Cells Infected with Hepatitis C Virus CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection Human Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into Cells High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins Studying Hepatitis C Virus: Making the Best of a Bad Virus N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection

P2860

Q21089621-0D064D48-6EC6-4B4F-9FD6-B88AD71EF872 Q21090524-6572A41C-27F8-4FCC-8AD8-C6D5CF78A2FF Q21558775-553CE22C-B69A-4BBE-95F4-F37BB980F451 Q24317564-16650A71-D771-4DE8-80FB-BB4681AC45C9 Q24598370-7179D675-3111-44C8-85AA-33A2A163F8EA Q24672232-68C19D83-EB94-4F26-B774-8B6F5BA7CA90 Q24676039-3CBAC3F3-2BE3-41B0-A51A-D57540149091 Q24681592-F9AE0532-A092-4528-B3F2-433EA0572986 Q24795289-F0059433-09A0-4AA3-9638-86307B656E6A Q26777338-2141EAB5-8273-4251-9BDF-FCB1AD557B3F Q26992256-F18D1792-D564-4AD1-BE52-57FE3FF3318F Q27002824-271C2E5D-693D-463C-B8A2-64C78F73959D Q27468561-BA8C5C7D-8CCF-43EC-9B6A-747E523008E3 Q27469468-51AC30A1-2A77-42B8-81B9-453B7B9D8DF1 Q27469837-731483F2-4DE9-4063-BA86-773C72AA7FAF Q27469843-928FB47C-F916-4BDC-8EF5-B648E45DEB3E Q27469844-9F069838-E52D-44BD-A3E1-A7C9B0B3BA95 Q27470013-60A90761-F9D8-47B7-ADCF-D70F28FF30FF Q27470798-488EDD3D-9DC0-441F-BCAE-626ACF0A63EA Q27470936-76283BA1-8009-4BFD-8008-ECDCA042D99A Q27472707-B752074A-D17D-48D5-AC45-36AC3024E288 Q27472768-B0AF5A79-5530-46C1-9640-25D5B3F3558E Q27472926-1F8BED87-FCD6-4D76-8D7F-4DB4C3C8F65B Q27472928-E8C73841-9E5A-47B7-9E6F-00DC92A1A4D3 Q27473222-6D5EB530-1CC6-437E-9B2D-F37906136984 Q27473226-2BBA055C-BFA4-4D87-86B3-59467844BBCF Q27477463-C2354862-4AC0-43E3-9528-50CD905620F1 Q27477468-5EA3CF01-C7C3-42D2-BEAA-5CEBE7A9DABF Q27477623-37D9FFB5-8FE3-47B6-8582-99EA1343D93B Q27477625-6F830018-A60D-41F6-863E-6D4931FCF0FD Q27477777-74503D44-8CD0-415D-A5ED-7BC3D8D2928C Q27478044-48351122-47C3-4B4F-8610-7036E19E6F02 Q27478378-F6435CFD-589B-4C95-8D3C-56F2ED598458 Q27480351-D3E1FAF2-DB20-44E3-84CF-011DB1C5C70C Q27480362-B42EAE90-4CE6-4892-8D63-E61FDA271370 Q27481010-0067FC5D-DF49-4690-A438-E6AB8F9E43FF Q27481012-FC98B5D3-3515-49E6-A47B-BDEFEFAF138F Q27481021-29F17989-DE74-498A-8B1D-266605CE716A Q27481034-16FACD1E-FB65-418A-8578-EAC22D6BEE14 Q27485442-2E302A69-1ED7-44AC-A960-3996A6340828

P2860

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

http://www.wikidata.org/entity/Q29619745

description

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2004

@ast

im Februar 2004 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: February 2004)

@en

wetenschappelijk artikel (gepubliceerd in 2004-02)

@nl

наукова стаття, опублікована в лютому 2004

@uk

مقالة علمية (نشرت في فبراير 2004)

@ar

name

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

@ast

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

@en

type

label

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

@ast

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

@en

prefLabel

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

@ast

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

@en

P1433

Q29619745-F37C683B-52C4-49E3-A289-5F45E5D066A2

P1476

Q29619745-C2701794-B7BF-49A3-9C34-19F328CE4086

P2093

Q29619745-0020BAA8-0A8C-4512-8B7F-DE62725834A5

Q29619745-0D553F53-7A7D-4B64-A66C-8B3C49F59578

Q29619745-5E3CEA2B-413F-454B-99BC-55B08875970E

Q29619745-6CA33126-4505-4D6C-90D6-D56C310DACB5

Q29619745-86D354B5-AB4F-4795-9884-4773690E5B4D

Q29619745-8B5A9BC3-1C26-43E2-9716-BCD035832709

P2860

Q29619745-02F7BC33-3B79-467B-AC3C-B633AAC9B2B3

Q29619745-08A78AAE-736F-4139-8A96-09CF5589D8A2

Q29619745-09A1D5FF-4591-4440-80F1-D70074445F4B

Q29619745-0AE7B352-17E6-40E5-8A19-079E110DB1DA

Q29619745-0C513129-9D01-4BFC-9C48-E04FA4504A04

Q29619745-1B142842-69F4-481A-BDE5-0EC45CC16533

Q29619745-1B91BAD0-C2EC-46F7-ABD6-4BDDB729F4FE

Q29619745-1F164444-5258-45F6-9CF1-7CC159EE36BB

Q29619745-27C81F0E-A8B6-41FE-B651-8754D7172713

Q29619745-2F4744F9-52A3-4626-941D-B6BA4DDDF8FE

P304

Q29619745-4B86C240-5277-4BB9-82AB-F0D1120E9A4C

P31

Q29619745-1329B4D4-2331-48D8-900F-75E5C88E0E9B

P3181

Q29619745-D04947D7-2FD7-42B2-A2F0-28FE7E93CD15

P356

Q29619745-71CA0E47-74F9-4A0D-933D-8D3EDEE04BEC

P407

Q29619745-CB626DEE-E1FA-44A7-910E-9234B84E3342

P433

Q29619745-1D83598D-A3F9-4A61-9D29-C6FCB23D6A63

P478

Q29619745-7139B1F4-87EE-4352-A44B-D5E97B30977C

P577

Q29619745-FBDD978D-A433-411E-94D1-C590B768E094

P698

Q29619745-51025A0C-B2C8-4AE3-B9D5-83328DFCC348

P921

Q29619745-adf20824-4152-59ae-b8fc-1f03017d80c2

P932

Q29619745-01A38DDB-1097-4E1A-9A68-8B683F248939

P3181

P356

JVI.78.3.1448-1455.2004

P1433

Journal of Virology

P1476

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

@en

P2093

Higginbottom A

http://www.w3.org/2001/XMLSchema#string

McKeating JA

http://www.w3.org/2001/XMLSchema#string

Monk P

http://www.w3.org/2001/XMLSchema#string

Randall G

http://www.w3.org/2001/XMLSchema#string

Rice CM

http://www.w3.org/2001/XMLSchema#string

Zhang J

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

Structure-function analysis of hepatitis C virus envelope-CD81 binding

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

P304

1448-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4323371

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.78.3.1448-1455.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14722300

http://www.w3.org/2001/XMLSchema#string

P921

Hepatitis C virus

P932

321402

http://www.w3.org/2001/XMLSchema#string